Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Colitis|Diarrhea|Malignant Genitourinary System Neoplasm|Melanoma|Lung Cancer|Ovarian Cancer|Uterine Cancer|Breast Cancer|Cervical Cancer
Interventions: PROCEDURE: Fecal Microbiota Transplantation|DRUG: Loperamide
Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)